Priya Shete, MD, MPH

Assistant Adjunct Professor

Priya Shete, MD is a pulmonary and critical care physician at UCSF who is focused on improving access to quality tuberculosis (TB) care for vulnerable populations globally and domestically. Her research and policy portfolio leverages methods in implementation science, social epidemiology, modeling, and health economics to describe patient-centered and health system-derived barriers to TB care.
Understanding the broad social, economic, and structural context in which TB patients interact with low-resourced health systems allows for the development of holistic, multi-sectoral interventions to improve patient and public health outcomes. Dr. Shete completed a degree in Biophysics from Johns Hopkins University and a received her M.D. from Yale, where she focused on the intersection between infectious disease and development for her thesis. She completed her internal medicine training and pulmonary and critical care fellowship training at UCSF. Her research experience is complemented by policy and program perspective gained while working at the Global TB Programme of the World Health Organization and the US Agency for International Development. Dr. Shete sees patients while attending on the Pulmonary Consult Service, in the Medical Intensive Care Unit, and in the Department of Public Health Tuberculosis Clinic at Zuckerberg San Francisco General Hospital.
Education
Certificate, 01/2019 - Implementation Science, University of California
2018 - Diversity, Equity, and Inclusion Champion Training, University of California
MPH, 12/2018 - Health Policy and Management, University of California
06/2015 - Pulmonary and Critical Care Medicine Fellowship, University of California
06/2010 - Residency in Internal Medicine, University of California
M.D., 05/2007 - Medicine, Yale University School of Medicine
B.A., 05/2001 - Biophysics, Johns Hopkins University
Publications
  1. Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States. 2020. PMID: 32916062


  2. Akl EA, Blazic I, Yaacoub S, Frija G, Chou R, Appiah JA, Fatehi M, Flor N, Hitti E, Jafri H, Jin ZY, Kauczor HU, Kawooya M, Kazerooni EA, Ko JP, Mahfouz R, Muglia V, Nyabanda R, Sanchez M, Shete PB, Ulla M, Zheng C, van Deventer E, Perez MDR. Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide. 2020. PMID: 32729811


  3. Chimoyi LA, Lienhardt C, Moodley N, Shete P, Churchyard GJ, Charalambous S. Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review. 2020. PMID: 32636313


  4. Parriott A, Kahn JG, Ashki H, Readhead A, Barry PM, Goodell AJ, Flood J, Shete PB. Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. 2020. PMID: 32735191


  5. Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. 2020. PMID: 32735183


  6. Vanderburg S, Alipanah N, Crowder R, Yoon C, Wang R, Thakur N, Slown K, Shete PB, Rofael M, Metcalfe JZ, Merrifield C, Marquez C, Malcolm K, Lipnick M, Jain V, Gomez A, Burns G, Brown LB, Berger C, Auyeung V, Cattamanchi A, Hendrickson CM. Management and Outcomes of Critically-Ill Patients with COVID-19 Pneumonia at a Safety-net Hospital in San Francisco, a Region with Early Public Health Interventions: A Case Series. 2020. PMID: 32511538


  7. Reza TF, Nalugwa T, Farr K, Nantale M, Oyuku D, Nakaweesa A, Musinguzi J, Vangala M, Shete PB, Tucker A, Ferguson O, Fielding K, Sohn H, Dowdy D, Moore DAJ, Davis JL, Ackerman SL, Handley MA, Katamba A, Cattamanchi A. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB). 2020. PMID: 32316993


  8. Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, Mugabe F, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Cattamanchi A, Katamba A. Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective. 2020. PMID: 32131814


  9. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. 2019. PMID: 31626560


  10. Adithya Cattamanchi, Christopher A. Berger, Priya B. Shete, Stavia Turyahabwe, Moses Joloba, David AJ Moore, J. Lucian Davis, Achilles Katamba. Implementation science to improve the quality of tuberculosis diagnostic services in Uganda. 2020. PMID:


  11. Cattamanchi A, Berger CA, Shete PB, Turyahabwe S, Joloba M, Moore DA, Davis LJ, Katamba A. Implementation science to improve the quality of tuberculosis diagnostic services in Uganda. 2019. PMID: 31879703


  12. Babirye D, Shete PB, Farr K, Nalugwa T, Ojok C, Nantale M, Oyuku D, Ayakaka I, Katamba A, Davis JL, Nadunga D, Joloba M, Moore D, Cattamanchi A. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. 2019. PMID: 31720434


  13. Gomes MGM, Oliveira JF, Bertolde A, Ayabina D, Nguyen TA, Maciel EL, Duarte R, Nguyen BH, Shete PB, Lienhardt C. Introducing risk inequality metrics in tuberculosis policy development. Volume 10 of Issue 1. 2019. PMID: 31171791


  14. Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. 2019. PMID: 31151255


  15. Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, Shete PB, Han AH, Fielding K, Joloba M, Mugabe F, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up. 2019. PMID: 31720425


  16. Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for tuberculosis elimination in California: An individual-based stochastic model. 2019. PMID: 30964878


  17. Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. 2019. PMID: 30904263


  18. Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. 2019. PMID: 30890135


  19. Reis-Santos B, Shete P, Bertolde A, Sales CM, Sanchez MN, Arakaki-Sanchez D, Andrade KB, Gomes MGM, Boccia D, Lienhardt C, Maciel EL. Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates. Volume 14 of Issue 2. 2019. PMID: 30794615


  20. Oliosi JGN, Reis-Santos B, Locatelli RL, Sales CMM, da Silva Filho WG, da Silva KC, Sanchez MN, de Andrade KVF, de Araújo GS, Shete PB, Pereira SM, Riley LW, Lienhardt C, Maciel ELN. Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study. Volume 7 of Issue 2. 2018. PMID: 30584050


  21. Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C. Defining a migrant-inclusive tuberculosis research agenda to end TB. Volume 22 of Issue 8. 2018. PMID: 29991390


  22. Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, Sanchez M, Maciel E, Rasella D, Shete P, Pedrazzoli D, Houben R, Chang S, Dowdy D. Modelling the impact of social protection on tuberculosis: the S-PROTECT project. Volume 18 of Issue 1. 2018. PMID: 29940906


  23. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. 2018. PMID: 29663958


  24. Shete PB, Dowdy DW. Measuring success: The challenge of social protection in helping eliminate tuberculosis. Volume 14 of Issue 11. 2017. PMID: 29112688


  25. Sismanidis C, Shete PB, Lienhardt C, Floyd K, Raviglione M. Harnessing the Power of Data to Guide Local Action and End Tuberculosis. Volume 216 of Issue suppl_7. 2017. PMID: 29117345


  26. Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L, Khan IH, Cattamanchi A. Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda. Volume 12 of Issue 8. 2017. PMID: 28767658


  27. Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy. 2017. PMID: 28633698


  28. Shete PB, Haguma P, Miller CR, Ochom E, Ayakaka I, Davis JL, Dowdy DW, Hopewell P, Katamba A, Cattamanchi A. Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda. 2015. PMID: 26162356


  29. Satyanarayana S, Subbaraman R, Shete P, Gore G, Das J, Cattamanchi A, Mayer K, Menzies D, Harries AD, Hopewell P, Pai M. Quality of tuberculosis care in India: a systematic review. 2015. PMID: 26056098


  30. Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. Volume 18 of Issue 5. 2007. PMID: 17854732


  31. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Volume 32 of Issue 1-2. 2006. PMID: 16858776


  32. Kolk SM, Whitman MC, Yun ME, Shete P, Donoghue MJ. A unique subpopulation of Tbr1-expressing deep layer neurons in the developing cerebral cortex. Volume 30 of Issue 4. 2005. PMID: 16188453


  33. Cohen NJ, Lauderdale DS, Shete PB, Seal JB, Daum RS. Physician knowledge of catch-up regimens and contraindications for childhood immunizations. Volume 111 of Issue 5 Pt 1. 2003. PMID: 12728067


  34. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Volume 29 of Issue 11. 2002. PMID: 12438901


  35. Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. Volume 186 of Issue 5. 2002. PMID: 12195353